Epigral Limited (EPIGRAL) — Financial Results
Epigral Limited reported Q4 FY26 revenue of ₹736 crores, up 22% QoQ, driven by 15% volume growth and 78-85% plant utilization, with EBITDA margin expanding to 23%. Full-year FY26 revenue declined 1% to ₹2,542 crores due to a 4% volume drop, but PAT reached ₹330 crores, including a one-time INR81 crore tax benefit. Management targets FY27 volume growth of 10-12% and expects resilience through product diversification despite geopolitical risks from West Asia affecting raw material prices and supply chains. Energy costs rose 15% due to conflict, but renewable energy adoption (currently 8-9% of power mix) is being leveraged for insulation. Net debt stood at INR508 crores with a debt-to-EBITDA ratio of 0.9.
About Epigral Limited (EPIGRAL)
Chemicals · Chemicals & Petrochemicals · Listed on NSE
📡 Get AI alerts when EPIGRAL files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track EPIGRAL — Free💡 Ask AI about this filing
📊 More EPIGRAL filings
- 🔴 Announcement — 14 July 2026 Epigral Limited received a reaffirmation of its CRISIL credit ratings on July 13, 2026, confirming a...
- Announcement — 7 July 2026 Epigral Limited announced the incorporation of a wholly owned subsidiary, Epigral Advanced Materials...
- 🔴 Announcement — 29 June 2026 No summary available
- Financial Results — 27 June 2026 Epigral Limited announced that its trading window for insiders will close on 1 July 2026 and remain ...
- Announcement — 10 June 2026 Epigral Limited announced a scheduled one-on-one video conference with Bellwether Capital on June 16...
🔥 Also filed on 6 May 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when EPIGRAL files new disclosures
Track EPIGRAL filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track EPIGRAL — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research